Deficiency of Lipocalin-2 Promotes Proliferation and Differentiation of Osteoclast Precursors via Regulation of c-Fms Expression and Nuclear Factorkappa B Activation
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Lipocalin-2 (LCN2), a small glycoprotein, has a pivotal role in diverse biological processes such as cellular proliferation and differentiation. We previously reported that LCN2 is implicated in osteoclast formation induced by receptor activator of nuclear factor-kappa B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF). In the present study, we used a knockout mouse model to further investigate the role of LCN2 in osteoclast development. Methods: Osteoclastogenesis was assessed using primary bone marrow-derived macrophages. RANKL and M-CSF signaling was determined by immunoblotting, cell proliferation by bromodeoxyuridine (BrdU) enzyme-linked immunosorbent assay (ELISA), and apoptosis by cell death detection ELISA. Bone morphometric parameters were determined using a micro-computed tomography system. Results: Our results showed that LCN2 deficiency increases tartrate-resistant acid phosphatase (TRAP)-positive multinucleated osteoclast formation in vitro, a finding that reflects enhanced proliferation and differentiation of osteoclast lineage cells. LCN2 deficiency promotes M-CSF-induced proliferation of bone marrow macrophages (BMMs), osteoclast precursors, without altering their survival. The accelerated proliferation of LCN2-deficient precursors is associated with enhanced expression and activation of the M-CSF receptor, c-Fms. Furthermore, LCN2 deficiency stimulates the induction of c-Fos and nuclear factor of activated T cells c1 (NFATc1), key transcription factors for osteoclastogenesis, and promotes RANKL-induced inhibitor of kappa B (IκBα) phosphorylation. Interestingly, LCN2 deficiency does not affect basal osteoclast formation in vivo, suggesting that LCN2 might play a role in the enhanced osteoclast development that occurs under some pathological conditions. Conclusions: Our study establishes LCN2 as a negative modulator of osteoclast formation, results that are in accordance with our previous findings.
Abstract
Background: Lipocalin-2 (LCN2), a small glycoprotein, has a pivotal role in diverse biological processes such as cellular proliferation and differentiation. We previously reported that LCN2 is implicated in osteoclast formation induced by receptor activator of nuclear factor-kappa B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF). In the present study, we used a knockout mouse model to further investigate the role of LCN2 in osteoclast development. Methods: Osteoclastogenesis was assessed using primary bone marrow-derived macrophages. RANKL and M-CSF signaling was determined by immunoblotting, cell proliferation by bromodeoxyuridine (BrdU) enzyme-linked immunosorbent assay (ELISA), and apoptosis by cell death detection ELISA. Bone morphometric parameters were determined using a micro-computed tomography system. Results: Our results showed that LCN2 deficiency increases tartrate-resistant acid phosphatase (TRAP)-positive multinucleated osteoclast formation in vitro, a finding that reflects enhanced proliferation and differentiation of osteoclast lineage cells. LCN2 deficiency promotes M-CSF-induced proliferation of bone marrow macrophages (BMMs), osteoclast precursors, without altering their survival. The accelerated proliferation of LCN2-deficient precursors is associated with enhanced expression and activation of the M-CSF receptor, c-Fms. Furthermore, LCN2 deficiency stimulates the induction of c-Fos and nuclear factor of activated T cells c1 (NFATc1), key transcription factors for osteoclastogenesis, and promotes RANKL-induced inhibitor of kappa B (IκBα) phosphorylation. Interestingly, LCN2 deficiency does not affect basal osteoclast formation in vivo, suggesting that LCN2 might play a role in the enhanced osteoclast development that occurs under some pathological conditions. Conclusions: Our study establishes LCN2 as a negative modulator of osteoclast formation, results that are in accordance with our previous findings.
참고문헌 (31)
- Boyle WJ, "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)
- Teitelbaum SL, "Genetic regulation of osteoclast development and function", Nat Rev Genet, 4, pp.638~649 (2003)
- Jaworowski A, "Roles of the mitogen-activated protein kinase family in macrophage responses to colony stimulating factor-1 addition and withdrawal", J Biol Chem, 274, pp.15127~15133 (1999)
- Takeshita S, "c-Fms tyrosine 559 is a major mediator of M-CSF-induced proliferation of primary macrophages", J Biol Chem, 282, pp.18980~18990 (2007)
- Valledor AF, "The differential time-course of extracellular-regulated kinase activity correlates with the macrophage response toward proliferation or activation", J Biol Chem, 275, pp.7403~7409 (2000)
- Kelley TW, "Macrophage colony-stimulating factor promotes cell survival through Akt", protein kinase B, 1999, pp.274, 26393~26398
- Zhou P, "SHIP1 negatively regulates proliferation of osteoclast precursors via Akt-dependent alterations in D-type cyclins and p27", J Immunol, 177, pp.8777~8784 (2006)
- Kim HJ, "Glucocorticoids suppress bone formation via the osteoclast", J Clin Invest, 116, pp.2152~2160 (2006)
- Takayanagi H, "Induction and activation of the transcription factor NFATc1(NFAT2)integrate RANKL signaling in terminal differentiation of osteoclasts", Dev Cell, 3, pp.889~901 (2002)
- Flo TH, "Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron", Nature, 432, pp.917~921 (2004)
- Goetz DH, "The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition", Mol Cell, 10, pp.1033~1043 (2002)
- Berger T, "Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury", Proc Natl Acad Sci U S A, 103, pp.1834~1839 (2006)
- Devireddy LR, "A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake", Cell, 123, pp.1293~1305 (2005)
- Lee S, "A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia", J Immunol, 179, pp.3231~3241 (2007)
- Nelson AM, "Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cells", J Clin Invest, 118, pp.1468~1478 (2008)
- Miharada K, "Lipocalin 2-mediated growth suppression is evident in human erythroid and monocyte", macrophage lineage cells, 2008, pp.215, 526~537
- Miharada K, "Lipocalin 2 functions as a negative regulator of red blood cell production in an autocrine fashion", Faseb j, 19, pp.1881~1883 (2005)
- Bolignano D, "Neutrophil gelatinase-associated lipocalin(NGAL)as a marker of kidney damage", Am J Kidney Dis, 52, pp.595~605 (2008)
- Yang J, "An iron delivery pathway mediated by a lipocalin", Mol Cell, 10, pp.1045~1056 (2002)
- Kim HJ, "Lipocalin-2 inhibits osteoclast formation by suppressing the proliferation and differentiation of osteoclast lineage cells", Exp Cell Res, 334, pp.301~309 (2015)
- Jeon S, "Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury", J Biol Chem, 288, pp.24116~24127 (2013)
- Kim HJ, "The tyrosine kinase inhibitor GNF-2 suppresses osteoclast formation and activity", J Leukoc Biol, 95, pp.337~345 (2014)
- Kodama H, "Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells", J Exp Med, 173, pp.1291~1294 (1991)
- Wiktor-Jedrzejczak W, "Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op", op) mouse, 1990, pp.87, 4828~4832
- Dai XM, "Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects", Blood, 99, pp.111~120 (2002)
- Ishida A, "Transforming growth factor-beta induces expression of receptor activator of NF-kappa B ligand in vascular endothelial cells derived from bone", J Biol Chem, 277, pp.26217~26224 (2002)
- Wang ZQ, "Bone and haematopoietic defects in mice lacking c-fos", Nature, 360, pp.741~745 (1992)
- Kim HJ, "The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo", Proc Natl Acad Sci U S A, 106, pp.2325~2330 (2009)
- Kim HJ, "Fyn promotes proliferation, differentiation, survival and function of osteoclast lineage cells", J Cell Biochem, 111, pp.1107~1113 (2010)
- Novack DV, "The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis", J Exp Med, 198, pp.771~781 (2003)
- Shashidharamurthy R, "Differential role of lipocalin 2 during immune complex-mediated acute and chronic inflammation in mice", Arthritis Rheum, 65, pp.1064~1073 (2013)